(MBG) Mercedes-Benz - Ratings and Ratios
Cars, Vans, Financing, Parts, Mobility
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.25% |
| Yield on Cost 5y | 12.18% |
| Yield CAGR 5y | 33.60% |
| Payout Consistency | 75.7% |
| Payout Ratio | 48.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Value at Risk 5%th | 37.3% |
| Relative Tail Risk | -1.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.64 |
| Alpha | 13.29 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.483 |
| Beta | 0.203 |
| Beta Downside | 0.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.38% |
| Mean DD | 13.90% |
| Median DD | 14.81% |
Description: MBG Mercedes-Benz December 03, 2025
Mercedes-Benz Group AG (ticker MBG) is a German-based, globally active automotive manufacturer organized into three segments: Mercedes-Benz Cars, Mercedes-Benz Vans, and Mercedes-Benz Mobility. The firm designs, produces and sells passenger cars and commercial vans under the Mercedes-Benz, Mercedes-AMG, Mercedes-Maybach and G-Class marques, and also offers a suite of post-sale services-including financing, leasing, subscription, rental, fleet management, insurance brokerage and digital charging/payment platforms.
Key recent metrics (2023) show total revenue of €150 bn, with EV (battery-electric and plug-in hybrid) sales representing roughly 23 % of vehicle deliveries-a figure that has risen 12 pp year-over-year, reflecting the impact of Europe’s stricter CO₂-emission standards and growing consumer demand for electrified mobility. The company’s EBIT margin stood at 9.8 %, supported by a 7 % YoY increase in R&D spend focused on next-generation powertrains and autonomous-driving software. A material sector driver is the EU’s “Fit for 55” package, which is accelerating the shift toward zero-emission vehicles and pressuring legacy ICE production.
For a deeper, data-driven analysis of MBG’s valuation and scenario outlook, the ValueRay research hub offers a concise, model-backed overview worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (6.25b TTM) > 0 and > 6% of Revenue (6% = 8.22b TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.28% (prev 18.64%; Δ -3.36pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 20.80b > Net Income 6.25b (YES >=105%, WARN >=100%) |
| Net Debt (88.68b) to EBITDA (15.57b) ratio: 5.70 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (962.9m) change vs 12m ago 0.57% (target <= -2.0% for YES) |
| Gross Margin 17.85% (prev 19.90%; Δ -2.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 52.90% (prev 56.26%; Δ -3.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 67.13 (EBITDA TTM 15.57b / Interest Expense TTM 125.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.23
| (A) 0.08 = (Total Current Assets 97.27b - Total Current Liabilities 76.34b) / Total Assets 255.84b |
| (B) 0.30 = Retained Earnings (Balance) 75.62b / Total Assets 255.84b |
| (C) 0.03 = EBIT TTM 8.39b / Avg Total Assets 258.93b |
| (D) 0.49 = Book Value of Equity 79.99b / Total Liabilities 163.23b |
| Total Rating: 2.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.66
| 1. Piotroski 4.50pt |
| 2. FCF Yield 10.06% |
| 3. FCF Margin 10.74% |
| 4. Debt/Equity 1.12 |
| 5. Debt/Ebitda 5.70 |
| 6. ROIC - WACC (= 4.09)% |
| 7. RoE 6.77% |
| 8. Rev. Trend -43.88% |
| 9. EPS Trend -66.41% |
What is the price of MBG shares?
Over the past week, the price has changed by -1.30%, over one month by +3.15%, over three months by +12.84% and over the past year by +20.32%.
Is MBG a buy, sell or hold?
What are the forecasts/targets for the MBG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.8 | 5.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 67.1 | 13.2% |
MBG Fundamental Data Overview December 21, 2025
Market Cap EUR = 57.62b (57.62b EUR * 1.0 EUR.EUR)
P/E Trailing = 9.2346
P/E Forward = 9.7752
P/S = 0.4207
P/B = 0.6355
P/EG = 3.5049
Beta = 0.726
Revenue TTM = 136.97b EUR
EBIT TTM = 8.39b EUR
EBITDA TTM = 15.57b EUR
Long Term Debt = 62.33b EUR (from longTermDebt, last quarter)
Short Term Debt = 38.35b EUR (from shortTermDebt, last quarter)
Debt = 102.34b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 88.68b EUR (from netDebt column, last quarter)
Enterprise Value = 146.30b EUR (57.62b + Debt 102.34b - CCE 13.67b)
Interest Coverage Ratio = 67.13 (Ebit TTM 8.39b / Interest Expense TTM 125.0m)
FCF Yield = 10.06% (FCF TTM 14.71b / Enterprise Value 146.30b)
FCF Margin = 10.74% (FCF TTM 14.71b / Revenue TTM 136.97b)
Net Margin = 4.56% (Net Income TTM 6.25b / Revenue TTM 136.97b)
Gross Margin = 17.85% ((Revenue TTM 136.97b - Cost of Revenue TTM 112.53b) / Revenue TTM)
Gross Margin QoQ = 15.58% (prev 16.41%)
Tobins Q-Ratio = 0.57 (Enterprise Value 146.30b / Total Assets 255.84b)
Interest Expense / Debt = 0.02% (Interest Expense 22.0m / Debt 102.34b)
Taxrate = -39.67% (negative due to tax credits) (-338.0m / 852.0m)
NOPAT = 11.72b (EBIT 8.39b * (1 - -39.67%)) [negative tax rate / tax credits]
Current Ratio = 1.27 (Total Current Assets 97.27b / Total Current Liabilities 76.34b)
Debt / Equity = 1.12 (Debt 102.34b / totalStockholderEquity, last quarter 91.71b)
Debt / EBITDA = 5.70 (Net Debt 88.68b / EBITDA 15.57b)
Debt / FCF = 6.03 (Net Debt 88.68b / FCF TTM 14.71b)
Total Stockholder Equity = 92.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 6.25b / Total Assets 255.84b)
RoE = 6.77% (Net Income TTM 6.25b / Total Stockholder Equity 92.37b)
RoCE = 5.42% (EBIT 8.39b / Capital Employed (Equity 92.37b + L.T.Debt 62.33b))
RoIC = 6.54% (NOPAT 11.72b / Invested Capital 179.15b)
WACC = 2.45% (E(57.62b)/V(159.96b) * Re(6.76%) + D(102.34b)/V(159.96b) * Rd(0.02%) * (1-Tc(-0.40)))
Discount Rate = 6.76% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.91%
[DCF Debug] Terminal Value 75.40% ; FCFE base≈12.31b ; Y1≈10.31b ; Y5≈7.66b
Fair Price DCF = 146.2 (DCF Value 140.73b / Shares Outstanding 962.9m; 5y FCF grow -19.68% → 3.0% )
EPS Correlation: -66.41 | EPS CAGR: -33.09% | SUE: 4.0 | # QB: 1
Revenue Correlation: -43.88 | Revenue CAGR: -2.42% | SUE: -0.95 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.76 | Chg30d=-0.174 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=6.82 | Chg30d=+0.001 | Revisions Net=-1 | Growth EPS=+16.3% | Growth Revenue=+1.2%